Objective: The aim was to investigate whether nicorandil suppresses th
e rise in coronary vascular resistance that occurs during stimulation
of the sympathetic nerve supply to the heart and, if so, what are the
mechanisms of action. Methods: The effects of nicorandil on coronary v
ascular resistance during ventrolateral cardiac nerve stimulation and
on the reactivity of the coronary vasculature to intracoronary infusio
n of noradrenaline or neuropeptide Y (NPY) were examined under beta re
ceptor blockade. The effects of nicorandil on the overflow of noradren
aline and NPY during ansae subclaviae stimulation were compared with t
hose in a control group and in a group treated with glyceryl trinitrat
e and N-omega-nitro-L-arginine (L-NNA) under both alpha and beta recep
tor blockade with vagotomy. Results: Intracoronary infusion of nicoran
dil decreased coronary vascular resistance prior to cardiac nerve stim
ulation, and during stimulation it suppressed the percentage increase
in resistance from the prestimulation value. Nicorandil suppressed the
reactivity of the coronary vasculature to exogenous noradrenaline and
NPY. Intra-atrial infusion of nicorandil significantly reduced the ov
erflow of NPY but not of noradrenaline during stimulation of the ansae
subclaviae at 20 Hz. This suppressive effect was not observed in the
glyceryl trinitrate + L-NNA group. Conclusions: Nicorandil reduces sym
pathetic coronary vasoconstriction by decreasing the reactivity of the
vasculature to sympathetic neurotransmitters and by suppressing NPY o
verflow during cardiac sympathetic nerve stimulation. The suppressive
action on NPY overflow is thought to be due to the opening of ATP sens
itive potassium channels in the sympathetic nerve endings rather than
to a glyceryl trinitrate-like action of nicorandil.